Ref.: BL-RE-106561Manufacturer ref.: EM29RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.
CD178 is a type II membrane protein with the N-terminal end in the cytoplasm and the C-terminal region extending into the extracellular space. Its receptor, FasR, is a type I membrane protein of cellular surface...
CD178 is a type II membrane protein with the N-terminal end in the cytoplasm and the C-terminal region extending into the extracellular space. Its receptor, FasR, is a type I membrane protein of cellular surface...
CD178 is a type II membrane protein with the N-terminal end in the cytoplasm and the C-terminal region extending into the extracellular space. Its receptor, FasR, is a type I cell surface membrane protein and a member of the NGF TNFet receptor family. As a member of the TNF-cytokine family, CD178 induces apoptosis during interaction with FasR. CD178 may exist as a bound (45 kD) or soluble (26 kD) membrane. The soluble protein can be released from the cells during cleavage by metalloproteinases. The binding of CD178 to Fas leads to receptor oligomerization and triggers death of apoptotic cells through the interaction of other proteins. CD178 is expressed predominantly in activated T-cells and natural killer cells, and also in tissues of immunological sites such as testicles and eyes. CD178 expression is also reported in a variety of tissues such as thymus, liver, lovary, lung, heart and kidney. It is assumed that CD178 induction of apoptosis is predominantly involved in antiviral immune responses. CD178 is a cell surface molecule belonging to the tumour necrosis factor family, and binds to its Fas receptor, thus inducing l-apoptosis. Different cells express Fas, where CD178 is expressed mainly on activated T cells. FAS and CD178 are involved in the downward regulation of immune reactions as well as T-cell cytotoxicity. CD178 concentration was also shown to be associated with atherosclerosis and inflammatory disease in patients with hypertension
Sensitivity
Sensitivity of dosage: 8 pg/ml.
Measurement range
Dose range: 8 to 2,000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.
Target
Target: Ligand Fas (CD178).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17758063
Specifications
Accession number
P41047
Dose range
8 to 2.000 pg/ml
Sensitivity of the dosage
8 pg/ml
Conjugate
Biotin
Product type
ELISA
Type of sample
Plasma, Serum, Surnatant
For use with (equipment)
Colorimetric microplate reader
Genetic identification (Enter)
14103
Gene symbol(s)
Fasl
Coefficient of inter-dose variation
< 12%
Coefficient of intra-dose variation
< 10%
Contents of kits
96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dye
HRP
Quantity
10 x 96 tests
Regulatory status
RUO
Target
Ligand Fas (CD178)
Test time
1 h 20 min
Physical characteristics
Volume of sample
Serum, 50 μl-Plasma, 50 μl-Surnatant, 50 μl
Storage and shipping
Storage conditions
2°C to 8°C
Total duration of dosing
4 h 45 min
Origin and customs
Manufacturer ref.
EM29RBX10
Country of origin
United States
HS customs code
3002 12 00 00
A question or a specific configuration? Contact us for a quote.